"Curing neurodegenerative diseases through brain infusion"
The start-up InBrain Pharma, supported by SATT Nord, will be present at the innovation course organized during the Medef Entrepreneurs' University.
July 6 from 9:00 a.m. to 10:30 a.m. at the Cité des échanges in Marcq en Baroeul.
InBrain PHARMA:Neurodegenerative diseases affect millions of people worldwide and are becoming more prevalent as the population ages. Despite numerous therapeutic approaches having been tested, no treatment currently available can slow the progression of these diseases. InBrain Pharma's concept consists of administering the treatment directly into the brain in order to remove the natural barriers that prevent treatments from working, avoid adverse effects in peripheral organs (heart, liver, kidneys, etc.) and adjust the dose precisely to the patient's needs. The relevance of this approach will be demonstrated by the first project on the new treatment for Parkinson's disease.
Contact: Matthieu Fisichella – CEO: matthieu.fisichella@sattnord.fr – Tel: +33 (0)6 13 84 37 56